It is safe to say that we now have a treatment modality available in SubCyclo with an excellent side effect profile that leaves us to think about how to best use this technology and in which areas we can use this gentler form of treatment.
I am convinced that ciliary body transillumination on patients undergoing SubCyclo procedures offers benefits not only in the optimal probe placement but also inthe therapeutic outcome.
In 2021, SLT laser therapy should be considered as a preferred first line treatment for glaucoma treatment and SubCyclo favored as an alternative treatment option to surgery
Glaucoma is a leading cause of irreversible blindness affecting approximately 60 million people globally 40 years of age and older.􀄦 Glaucoma is a disease that cannot be ignored, and the need for signi􀃶cant changes in how we diagnose, manage, and treat must be examined and applied whenever possible.
Glaucoma management has traditionally taken a stepped approach based on the level of risk involved. The low-risk treatment option is medication. Next are laser/selective laser trabeculoplasty (SLT), MIGS, and incisional surgery. It ends with the highest risk option of cyclodestructive procedures.
Micropulse Transscleral diode laser cyclophotocoagulation (MP-TSCPC) is an established method of treatment for refractory glaucoma. This study evaluates the efficacy in terms of reduction in intraocular pressure and/or treatment amount, and safety and side effects of the ciliary bodies using a subthreshold laser with a duty cycle of 31.3% with Supra 810 nm Subliminal Quantel Medical, at one year in patients with refractory glaucoma.
Micropulse Transscleral Cyclophotocoagulation (MP-TSCP) is a recently developed cyclodestructive procedure less aggressive than conventional TSCP. In this study, we aimed to evaluate the safety and efficacy of MP-TSCP in a real-life setting.
Since 1993, Quantel Medical develops, manufactures and markets innovative medical laser and ultrasound solutions.
World leader in ophthalmology, its lasers and ultrasounds are designed to diagnose and treat the four main causes of blindness: cataracts, glaucoma, diabetic retinopathy and macular degeneration; and also dry eye disease.
"*" indicates required fields
